Indonesia’s health technology startup ecosystem is experiencing unprecedented growth, with ProSpace Indonesia’s Digital Health Report revealing $870 million in venture capital investment during 2024, triple the amount secured in 2023. The funding supports 147 active healthtech startups across telemedicine, health information systems, digital pharmacy, and diagnostic innovation categories.
Telemedicine platforms lead in user adoption, with monthly active users across all platforms reaching 23.5 million. Meanwhile, digital pharmacies have captured 18% of the prescription drug market, significantly expanding access in areas with limited physical pharmacy presence.
“Indonesia’s healthtech sector has evolved from proving basic concepts to demonstrating sustainable business models and meaningful health outcomes,” explains Surya Wijaya, Digital Health Analyst at ProSpace. “The integration with formal healthcare systems has been particularly important for creating lasting impact.”
Artificial intelligence applications show growing clinical adoption, with diagnostic assistance tools now utilized in 320 healthcare facilities nationwide. Meanwhile, electronic medical record systems have been implemented in 63% of hospitals, up from 41% in 2023.
Government policies increasingly support digital health adoption, with telemedicine consultations now reimbursable through the national health insurance scheme under certain conditions. Regulatory sandboxes enable controlled innovation while maintaining patient safety standards.
Challenges include ensuring equitable access across socioeconomic groups and addressing technical interoperability between different healthcare technology systems.
For healthtech investment opportunities: Phone: +62 21 5799 8989 Email: info@prospaceindonesia.com Follow @prospace.indonesia on Instagram for updates